Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEfficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen
Contraception, 06/19/09
Hernadi L et al. - The study was conducted to assess the efficacy of a low-dose combined oral contraceptive (COC) containing drospirenone (drsp) 3 mg/ethinylestradiol (EE) 20 mcg administered for 24 days of active treatment followed by a 4-day hormone-free interval (24/4 regimen). Drospirenone 3 mg/EE 20 mcg 24/4 is a highly effective COC in nonobese women.
Related Articles
Contraceptive counselling to teenagers at abortion visits - A qualitative content analysis
The European Journal of Contraception & Reproductive Health Care, 10/30/09
Relevance Score: 92%
The IUD is the most popular long-acting contraceptive amongst Europeans
EurekAlert, 10/29/09
Relevance Score: 91%
Contraceptive Choices of Women 35-44 Years of Age: Findings From the Behavioral Risk Factor Surveillance System
Annals of Epidemiology, 10/14/09
Relevance Score: 91%
Contraceptive Use and Contraception Type in Women by Body Mass Index Category
Women's Health Issues, 11/04/09
Relevance Score: 90%
Contraceptive usage among Jamaican women with sickle cell disease
Contraception, 10/20/09
Relevance Score: 90%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Temporal Reduction of HIV Type 1 Viral Load in Breast Milk by Single-Dose Nevirapine during Prevention of MTCT
AIDS Research and Human Retroviruses, 12/18/09
Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome
European Journal of Pain, 12/18/09
Low levels of steroid-metabolizing hepatic enzyme activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose
Journal of Orthopaedic Science, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor